AAAAAA

   
Results: 1-13 |
Results: 13
RANDOMIZED PHASE-III STUDY OF GEMCITABINE CISPLATIN VERSUS MITOMYCIN/IFOSFAMIDE/CISPLATIN IN ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC)/
Authors: SCAGLIOTTI G CRINO L CONTE PF RINALDI M DEMARINIS F GRIDELLI C
Citation: G. Scagliotti et al., RANDOMIZED PHASE-III STUDY OF GEMCITABINE CISPLATIN VERSUS MITOMYCIN/IFOSFAMIDE/CISPLATIN IN ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC)/, Annals of oncology, 9, 1998, pp. 407-407
DOUBLE-BLIND, DOSE-FINDING STUDY OF 4 INTRAVENOUS DOSES OF DEXAMETHASONE IN THE PREVENTION OF CISPLATIN-INDUCED ACUTE EMESIS
Authors: ROILA F BALLATORI E DEANGELIS V TONATO M DELFAVERO A CICCARESE G BASURTO C CICCARESE G PALLADINO MA PORROZZI S PICCIAFUOCO M CONTU A OLMEO N PAZZOLA A PILO L TATEO S CHIAPPARINI I MORANA S LUCCHINO S RICCI S ANTONUZZO A ALLEGRINI G GALLI L CONTE PF MASSIDDA B IONTA MT SCANU A MURRU R PICECE V CIRILLO M MAGAROTTO R NUZZO A LAUDADIO L SABLONE MG LOCATELLI MC DANTONA A LUPORINI G SCAGLIOTTI G SELVAGGI G MATTEI A FAVALLI G GAMBINO A FAVA S GRIMI E SCARFONE G BOLIS MC ALESSANDRONI P CATALANO G BONI C MORETTI G CORTESI E MARTELLI O ANTIMI M BELLINI V BUZZI E BRUGIA M GRECCHI M CLERICO M MONTINARI F DONATI D SANSONI E
Citation: F. Roila et al., DOUBLE-BLIND, DOSE-FINDING STUDY OF 4 INTRAVENOUS DOSES OF DEXAMETHASONE IN THE PREVENTION OF CISPLATIN-INDUCED ACUTE EMESIS, Journal of clinical oncology, 16(9), 1998, pp. 2937-2942
RANDOMIZED STUDY OF PACLITAXEL-CISPLATIN VERSUS CISPLATIN-TENIPOSIDE IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER
Authors: GIACCONE G SPLINTER TAW DEBRUYNE C KHO GS LIANES P VANZANDWIJK N PENNUCCI MC SCAGLIOTTI G VANMEERBEECK J VANHOESEL Q CURRAN D SAHMOUD T POSTMUS PE
Citation: G. Giaccone et al., RANDOMIZED STUDY OF PACLITAXEL-CISPLATIN VERSUS CISPLATIN-TENIPOSIDE IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 16(6), 1998, pp. 2133-2141
DELAYED EMESIS INDUCED BY MODERATELY EMETOGENIC CHEMOTHERAPY - DO WE NEED TO TREAT ALL PATIENTS
Authors: BALLATORI E ROILA F DEANGELIS V RIVA E BARBIERI P DELFAVERO A BASURTO C CICCARESE G PALLADINO MA MOSCONI AM ANASTASI P PICCIAFUOCO M CAMPORA E CHIARA S COGNETTI F FERRARESI V FABI A TONACHELLA R CIRULLI S SABBATINI R FEDERICO M TRASSOLDATI A SILINGARDI V DONATI D MAESTRI A MALACARNE P RICCI S ANTONUZZO A ALLEGRINI G CONTE PF SALVATI F NUNZIATI F ANTILLI A CATALANO G CASCINU S DICOSTANZO F TAGLIAVENTI M ZANIBONI A MERIGGI F CORTESI E RAMPONI S LOCATELLI MC SANTORO A ZUCCHINELLI P MANTELLINI E FERRETTI G BONI C MORETTI G SCAGLIOTTI G DANIELE O LISSONI A TATEO S
Citation: E. Ballatori et al., DELAYED EMESIS INDUCED BY MODERATELY EMETOGENIC CHEMOTHERAPY - DO WE NEED TO TREAT ALL PATIENTS, Annals of oncology, 8(6), 1997, pp. 561-567
CISPLATIN-GEMCITABINE COMBINATION IN ADVANCED NON-SMALL-CELL LUNG-CANCER - A PHASE-II STUDY
Authors: CRINO L SCAGLIOTTI G MARANGOLO M FIGOLI F CLERICI M DEMARINIS F SALVATI F CRUCIANI G DOGLIOTTI L PUCCI F PACCAGNELLA A ADAMO V ALTAVILLA G INCORONATO P TRIPPETTI M MOSCONI AM SANTUCCI A SORBOLINI S OLIVA C TONATO M
Citation: L. Crino et al., CISPLATIN-GEMCITABINE COMBINATION IN ADVANCED NON-SMALL-CELL LUNG-CANCER - A PHASE-II STUDY, Journal of clinical oncology, 15(1), 1997, pp. 297-303
STANDARD VERSUS ALTERNATING NON-CROSS-RESISTANT CHEMOTHERAPY IN EXTENSIVE SMALL-CELL LUNG-CANCER - AN EORTC PHASE-III TRIAL
Authors: POSTMUS PE SCAGLIOTTI G GROEN HJM GOZZELINO F BURGHOUTS JTW CURRAN D SAHMOUD T KIRKPATRICK A GIACCONE G SPLINTER TAW
Citation: Pe. Postmus et al., STANDARD VERSUS ALTERNATING NON-CROSS-RESISTANT CHEMOTHERAPY IN EXTENSIVE SMALL-CELL LUNG-CANCER - AN EORTC PHASE-III TRIAL, European journal of cancer, 32A(9), 1996, pp. 1498-1503
ONDANSETRON VERSUS GRANISETRON, BOTH COMBINED WITH DEXAMETHASONE, IN THE PREVENTION OF CISPLATIN-INDUCED EMESIS
Authors: BASURTO C CICCARESE G PALLADINO MA PICCIAFUOCO M RICCI S ANTONUZZO A ALLEGRINI G CONTE PF COGNETTI F CIRULLI S COLELLA E MILELLA M SAVARESE A STANI S CONTU A OLMEO N PIRO S PIRAS M PILO L PILO P NUZZO A URSINI LA TARABORRELLI M MELENA S BASILICO L BUZZI F BRUGIA M TRIPPA F DELRIO S TAGLIAVENTI M PICECE V CASSANDRINI P CIRILLO M MAGAROTTO R RECALDIN E CLERICO M BARTETTO O MORANDINI MP BAINOTTI L BONI C MORETTI G SAVOLDI L TATEO S CHIAPPARINI I ZARA C CATALANO G CASCINU S ALESSANDRONI P MASSIDDA B IONTA MT PEDDITZI E MONTINARI F CASARTELLI C MANDELLI D ROTONDO SG LELLI G CILENTI G MORRITTI M PUSCEDDU G SALARIS G PRESTI ML FAVALLI G GAMBINO A RAVELLI V CORTESI E GIOACCHINI N OLIVA A DAZZI C MONTANARI L CRUCIANI G DEMARINIS F SCARFONE G BOLIS MC SCAGLIOTTI G SELVAGGI G DONATI D MALACARNE P SANTORO A PARRA HS LOCATELLI MC LUPORINI G SANSONI E MATERA G FAVA C
Citation: C. Basurto et al., ONDANSETRON VERSUS GRANISETRON, BOTH COMBINED WITH DEXAMETHASONE, IN THE PREVENTION OF CISPLATIN-INDUCED EMESIS, Annals of oncology, 6(8), 1995, pp. 805-810
IN-VIVO EFFECT OF HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) ON NEUTROPHIL GM-CSF RECEPTORS
Authors: STACCHINI A FUBINI L GATTI E MUTTI L PIACIBELLO W SANAVIO F SCAGLIOTTI G POZZI E AGLIETTA M
Citation: A. Stacchini et al., IN-VIVO EFFECT OF HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) ON NEUTROPHIL GM-CSF RECEPTORS, Leukemia, 9(4), 1995, pp. 665-670
PERSISTENCE OF EFFICACY OF 3 ANTIEMETIC REGIMENS AND PROGNOSTIC FACTORS IN PATIENTS UNDERGOING MODERATELY EMETOGENIC CHEMOTHERAPY
Authors: BALLATORI E ROILA F DEANGELIS V TONATO M RIVA E BARBIERI P DELFAVERO A BASURTO C CICCARESE G PALLADINO MA MOSCONI AM ANASTASI P PICCIAFUOCO M CAMPORA E CHIARA S COGNETTI F FERRARESI V FABI A COLELLA E CIRULLI S SABBATINI R FEDERICO M BARBIERI F SILINGARDI V ANNA S DONATI D MAESTRI A MALACARNE P RICCI S ANTONUZZO A CONTE PF SALVATI F NUNZIATI F ANTILLI A CATALANO G CASCINU S DICOSTANZO F TAGLIAVENTI M ZANIBONI Z MERIGGI F CORTESI E CALABRO F CARLO S LUPORINI G DANTONA A SANTORO A GIACOBONE A MANTELLINI E FERRETTI G BONI C MORETTI G SCAGLIOTTI G DANIELE O LISSONI A TATEO S
Citation: E. Ballatori et al., PERSISTENCE OF EFFICACY OF 3 ANTIEMETIC REGIMENS AND PROGNOSTIC FACTORS IN PATIENTS UNDERGOING MODERATELY EMETOGENIC CHEMOTHERAPY, Journal of clinical oncology, 13(9), 1995, pp. 2417-2426
DIFFERENTIAL EXPRESSION OF DNA TOPOISOMERASES IN NON-SMALL-CELL LUNG-CANCER AND NORMAL LUNG
Authors: GIACCONE G VANARKOTTE J SCAGLIOTTI G CAPRANICO G VANDERVALK P RUBIO G DALESIO O LOPEZ R ZUNINO F WALBOOMERS J PINEDO HM
Citation: G. Giaccone et al., DIFFERENTIAL EXPRESSION OF DNA TOPOISOMERASES IN NON-SMALL-CELL LUNG-CANCER AND NORMAL LUNG, Biochimica et biophysica acta, N. Gene structure and expression, 1264(3), 1995, pp. 337-346
DEXAMETHASONE, GRANISETRON, OR BOTH FOR THE PREVENTION OF NAUSEA AND VOMITING DURING CHEMOTHERAPY FOR CANCER
Authors: ROILA F BALLATORI E DEANGELIS V TONATO M RIVA E PANZA MT DELFAVERO A BASURTO C CICCARESE G PALLADINO MA MOSCONI AM ANASTASI P PICCIAFUOCO M CAMPORA E CHIARA S ROSSO R COGNETTI F FERRARESI V FABI A TONACHELLA R CIRULLI S SABBATINI R FEDERICO M DEPENNI R SILINGARDI V DONATI D MAESTRI A MALACARNE P RICCI S MUTTINI MP CONTE PF SALVATI F NUNZIATI F SIGNORA M CATALANO G CASCINU S DICOSTANZO F TAGLIAVENTI M ZANIBONI A MERIGGI F CORTESI E TRINCA C LUPORINI G LOCATELLI MC SANTORO A ZUCCHINELLI P MANTELLINI E FERRETTI G BONI C MORETTI G SCAGLIOTTI G DANIELE O LISSONI A TATEO S
Citation: F. Roila et al., DEXAMETHASONE, GRANISETRON, OR BOTH FOR THE PREVENTION OF NAUSEA AND VOMITING DURING CHEMOTHERAPY FOR CANCER, The New England journal of medicine, 332(1), 1995, pp. 1-5
EUROPEAN-SCHOOL-OF-ONCOLOGY FIRST EURO-AMERICAN FORUM ON LUNG-CANCER TREATMENT
Authors: BUNN PA VANZANDWIJK N PASTORINO U AISNER J ALBERTO P ARRIAGADA R CARNEY D CORNIS R DITTRICH C GATZEMEIER U GINSBERG R GRECO FA HANSEN HH HARPER P HENRIKSSON R HUBER H KLENER P LECHEVALIER T LEWENSOHN R MURRAY N NIEDERLE N POSTMUS P ROSELL R SCAGLIOTTI G SCULIER JP SPLINTER T STAHEL R SYMANN M THATCHER N TONATO M TURRISI A
Citation: Pa. Bunn et al., EUROPEAN-SCHOOL-OF-ONCOLOGY FIRST EURO-AMERICAN FORUM ON LUNG-CANCER TREATMENT, European journal of cancer, 30A(5), 1994, pp. 710-713
COMBINATION OF CHEMOTHERAPY AND RECOMBINANT ALPHA-INTERFERON IN ADVANCED NONSMALL CELL LUNG-CANCER - MULTICENTRIC RANDOMIZED FONICAP TRIAL REPORT
Authors: ARDIZZONI A SALVATI F ROSSO R BRUZZI P RUBAGOTTI A PENNUCCI MC MARIANI GL DEMARINIS F PALLOTTA G ANTILLI A CRUCIANI AM RINALDI M TONACHELLA R FIORETTI M BARBERA S MANTELLINI E SORESI E PASTORINO G BELLI M FERRARA G VENTURINI M SCAGLIOTTI G SANTI L PORTALONE L CRIPPA M BORGHINI U BREMA F RIMOLDI R BANDERA M PIACENZA G ROMANO F COLANTUONI G BONSIGNORE G EPIS R ANDREOLA E SCAGLIOTTI E POZZI E BOTTA M CASTAGNETO B LANFRANCO C TESTORE F LUPPIS B DEPALMA M ROCCHI D BARACCO F CINQUEGRANA A RASO C BONAVIA M ROPOLO F
Citation: A. Ardizzoni et al., COMBINATION OF CHEMOTHERAPY AND RECOMBINANT ALPHA-INTERFERON IN ADVANCED NONSMALL CELL LUNG-CANCER - MULTICENTRIC RANDOMIZED FONICAP TRIAL REPORT, Cancer, 72(10), 1993, pp. 2929-2935
Risultati: 1-13 |